| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | KIAA1648 |
| Uniprot No | 0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-240aa |
| 活性数据 | MTMAVVASVCRNDLPSSREGAAPVGRRCLPSQMETAGKWHLFPPGVEMLVSGTPCHFSGH PPAPSWEIQHPHECGAQGHQLFHLLSARPVAPALHPQLTQQGLECAAALLEPVARVGGWE EDSRWQATGWGVQPEAHSGEEGLPARDAAHFVLHTLLGRVHGIALPILDALQGFLHLRGN WGKHWDAGAQASQTGGSVYSHQPGGNKPAWEDRRSALAVPQERGASKAHCPLGQGVSRRS |
| 分子量 | 52.8 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人KIAA1648蛋白的模拟参考文献示例(请注意，部分内容可能为虚构，实际文献需通过学术数据库验证)：
---
1. **《Efficient Expression and Purification of Recombinant Human KIAA1648 in HEK293 Cells》**
*作者：Zhang L, et al. (2022)*
**摘要**：本研究成功在HEK293哺乳动物细胞中表达了重组人KIAA1648蛋白，优化了亲和层析纯化方法，并验证了其可用于后续蛋白互作实验及功能研究。
2. **《Role of Recombinant KIAA1648 in DNA Damage Response Pathways》**
*作者：Smith R, et al. (2021)*
**摘要**：通过重组表达KIAA1648蛋白，发现其与BRCA1/2复合物相互作用，并在体外细胞模型中证明了其对DNA双链断裂修复的关键调控作用。
3. **《Crystal Structure Analysis of the N-terminal Domain of Human KIAA1648》**
*作者：Watanabe K, et al. (2020)*
**摘要**：利用重组表达的KIAA1648蛋白N端结构域进行X射线晶体学分析，揭示了其与微管结合相关的独特三维结构特征。
4. **《KIAA1648 as a Potential Biomarker in Glioblastoma: Insights from Recombinant Protein-based Assays》**
*作者：Chen X, et al. (2019)*
**摘要**：研究基于重组KIAA1648蛋白的血清学检测，发现其在胶质母细胞瘤患者中高表达，可能成为新型诊断标志物。
---
**提示**：实际文献检索建议通过PubMed、Google Scholar等平台，结合关键词“recombinant KIAA1648”或“KIAA1648 protein expression”，并核实其是否为该蛋白的官方命名(如部分基因可能已更名)。
**Background of Recombinant Human KIAA1648 Protein**
The KIAA1648 gene, identified through large-scale sequencing projects, encodes a protein with partially characterized functional domains and putative roles in cellular processes. While its exact biological mechanisms remain under investigation, KIAA1648 is speculated to contribute to intracellular signaling, cytoskeletal organization, or nucleic acid metabolism based on domain analysis (e.g., conserved motifs linked to enzymatic or binding activities). The protein is expressed in multiple tissues, with elevated levels observed in the brain, suggesting potential neurological relevance.
Recombinant human KIAA1648 protein is engineered via heterologous expression systems (e.g., mammalian, bacterial, or insect cells) to produce purified, functional protein for research. This enables studies on its structure, interactions, and role in disease contexts. Emerging evidence links dysregulation of KIAA1648 to certain cancers and neurodegenerative disorders, though causal relationships require validation. Its recombinant form is pivotal for generating antibodies, mapping binding partners, and screening for therapeutic compounds. Current research focuses on elucidating its molecular functions, post-translational modifications, and potential as a biomarker or drug target. Advances in recombinant technology continue to facilitate deeper exploration of KIAA1648’s contributions to cellular physiology and pathology.
×
